GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Jumpcan Pharmaceutical Co Ltd (SHSE:600566) » Definitions » Market Cap

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Market Cap : ¥35,471 Mil (As of May. 21, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Hubei Jumpcan Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hubei Jumpcan Pharmaceutical Co's share price for the quarter that ended in Mar. 2024 was ¥37.43. Hubei Jumpcan Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 922 Mil. Therefore, Hubei Jumpcan Pharmaceutical Co's market cap for the quarter that ended in Mar. 2024 was ¥34,503 Mil.

Hubei Jumpcan Pharmaceutical Co's quarterly market cap increased from Sep. 2023 (¥25,207 Mil) to Dec. 2023 (¥28,972 Mil) and increased from Dec. 2023 (¥28,972 Mil) to Mar. 2024 (¥34,503 Mil).

Hubei Jumpcan Pharmaceutical Co's annual market cap declined from Dec. 2021 (¥25,174 Mil) to Dec. 2022 (¥25,092 Mil) but then increased from Dec. 2022 (¥25,092 Mil) to Dec. 2023 (¥28,972 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hubei Jumpcan Pharmaceutical Co's Enterprise Value for Today is ¥24,229 Mil.


Hubei Jumpcan Pharmaceutical Co Market Cap Historical Data

The historical data trend for Hubei Jumpcan Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Jumpcan Pharmaceutical Co Market Cap Chart

Hubei Jumpcan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19,704.81 17,969.44 25,173.66 25,091.99 28,972.39

Hubei Jumpcan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26,270.46 26,787.02 25,207.40 28,972.39 34,503.24

Competitive Comparison of Hubei Jumpcan Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Jumpcan Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Jumpcan Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Jumpcan Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Hubei Jumpcan Pharmaceutical Co's Market Cap falls into.



Hubei Jumpcan Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Hubei Jumpcan Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥31.43*921.807
=¥28,972

Hubei Jumpcan Pharmaceutical Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥37.43*921.807
=¥34,503

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hubei Jumpcan Pharmaceutical Co  (SHSE:600566) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Hubei Jumpcan Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Hubei Jumpcan Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Business Description

Traded in Other Exchanges
N/A
Address
Heights Garden Road, Room 602 fashion, Shashi District, Jingzhou, Hubei, CHN
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatric. The company also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Headlines

No Headlines